Inari Soininen, Author at ERA4TB

Event

Project Update – 3th Consortium Meeting

The third ERA4TB Consortium Meeting took place last June 9th and 10th with the participation…

Inari SoininenJune 15, 2021

Press

COVID-19 highlights urgent need to reboot global effort to end tuberculosis [Press Release – WHO]

An estimated 1.4 million fewer people received care for tuberculosis (TB) in 2020 than in…

Inari SoininenMarch 26, 2021

Event

Consortium Meeting

On January 26th and 27th the second Consortium Meeting took place online to share the…

Inari SoininenFebruary 2, 2021

Event

Europa Press Digital Meetings: AIDS, tuberculosis and malaria in times of COVID-19

As part of their online initiative to allow experts to discuss a variety of topics,…

Inari SoininenNovember 30, 2020

News

ERA4TB at the Union World Conference

From 22 to 24 October took place the 51st Union World conference on lung health.…

Inari SoininenNovember 30, 2020

TWITTER

ERA4TB ProjectFollow

European Regimen Accelerator for Tuberculosis. Grant Agreement number: 853989 — ERA4TB

Retweet on Twitter ERA4TB Project Retweeted

9 Sep

Our @NICEComms portfolio of @IMI_JU and #Horizon2020 @EuropeanCommiss funded projects covers a number of methodological and therapeutic-area specific projects:
@IMI_EHDEN @HarmonynetEU @IMI2_NEURONET @HTx_H2020 @IMI_ERA4TB and @ValueDx

Looking forward to expanding it!

Reply on Twitter 1436037256247193600 Retweet on Twitter 14360372562471936008 Like on Twitter 143603725624719360012 Twitter 1436037256247193600

Retweet on Twitter ERA4TB Project Retweeted

27 Aug

OFERTA DE TRABAJO
Buscamos Técnico Superior de Gestión de la Investigación @unizar para el proyecto ERA4TB @IMI_ERA4TB
Toda la información en:
https://ae.unizar.es/?app=touz&opcion=mostrar&id=42176
Convocatoria PRI-039/2021.
Plazo de presentación de solicitudes del 30 de agosto al 3 de septiembre.

Reply on Twitter 1431223516737724424 Retweet on Twitter 14312235167377244247 Like on Twitter 14312235167377244248 Twitter 1431223516737724424

Retweet on Twitter ERA4TB Project Retweeted

25 Aug

Financing & #Investing: What's new with #funds, #incubators and #accelerators? Anders Karlén of @UU_University and @AMR_Combine coordinator presented the @IMI_JU @AMRAccelerator at the #AMRconference. Session with @ErinDuffyJ of @CARB_X & many more.

Reply on Twitter 1430522334822158340 Retweet on Twitter 14305223348221583404 Like on Twitter 14305223348221583407 Twitter 1430522334822158340

Retweet on Twitter ERA4TB Project Retweeted

24 Aug

#NewsUpdate: Technology is playing a crucial role to #EndTB by 2030. In a major breakthrough reported by @TheLancet, #ArtificialIntelligence has outperformed humans in reading chest x-rays for signs of tuberculosis. Read full study 👉 https://bit.ly/3sQFBk8

Reply on Twitter 1430186196186042382 Retweet on Twitter 143018619618604238228 Like on Twitter 143018619618604238241 Twitter 1430186196186042382

Retweet on Twitter ERA4TB Project Retweeted

5 Aug

@unizar @ARAID_ES we are working hard towards this end to develop not only new antibiotics but also new #Antimicrobials therapies based on already approved #drugrepurposing.
We are also developing new anti-TB drugs @IMI_ERA4TB 💪💪
#advocacy #Funds needed https://twitter.com/gardp_amr/status/1423204307927769089

Global Antibiotic R&D Partnership (GARDP)@gardp_amr

Vanessa Carter (@_FaceSA) is an international patient advocate for #AntimicrobialResistance (#AMR). She has used her personal experience of AMR to help change the lives of others. Vanessa tells her compelling story to GARDP➡️https://bit.ly/3s2SqHG

Reply on Twitter 1423221301028827143 Retweet on Twitter 14232213010288271432 Like on Twitter 14232213010288271434 Twitter 1423221301028827143

Inari Soininen

Project Update – 3th Consortium Meeting

COVID-19 highlights urgent need to reboot global effort to end tuberculosis [Press Release – WHO]

Consortium Meeting

Europa Press Digital Meetings: AIDS, tuberculosis and malaria in times of COVID-19

ERA4TB at the Union World Conference

Recent Posts

Categories

TWITTER

Acknowledgement:

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 853989.

The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and Global Alliance for TB Drug Development non profit organisation, Bill & Melinda Gates Foundation and University of Dundee.

Contact:

info@era4tb.org

The Project

Consortium

News

Result